In a patient with recent acute myocardial infarction and left‑ventricular dysfunction (ejection fraction ≤40 % or regional wall‑motion abnormalities), what is the preferred initial imaging test to assess myocardial viability?

Post-MI Myocardial Viability Testing: Preferred Initial Imaging

Cardiac MRI with late gadolinium enhancement (LGE-CMR) is the preferred initial imaging test for assessing myocardial viability in patients with recent acute myocardial infarction and left ventricular dysfunction. 1

Rationale for CMR as First-Line

The 2021 European Association of Cardiovascular Imaging (EACVI) expert consensus explicitly states that "CMR LGE is currently the reference method for clinical assessment of viability" 1. This recommendation is based on several key advantages:

Technical Superiority

• Near-histological precision: Spatial resolution of approximately 1×1 mm in-plane allows visualization of scar with exceptional detail 1
• Quantitative assessment: Transmural extent of scar can be precisely measured, with <25% transmurality indicating high probability of recovery and >75% indicating non-viability 1
• No ionizing radiation: Critical advantage over nuclear imaging techniques 1
• Comprehensive evaluation: Single study provides function, wall thickness, scar burden, and prognostic information 1

Diagnostic Performance

LGE-CMR demonstrates 91% sensitivity for predicting functional recovery, though specificity is moderate at 51% 1. The technique excels at ruling out viability (high negative predictive value) and provides incremental prognostic value beyond ejection fraction alone 1.

Practical Implementation Algorithm

Step 1: Perform LGE-CMR (10-15 minutes post-gadolinium)

• Acquire short-axis stack plus 2-, 3-, and 4-chamber long-axis views
• Use phase-sensitive inversion recovery sequences 1
• Quantify transmural extent of enhancement per segment

Step 2: Interpret Results

• No LGE or <25% transmurality = Viable myocardium, high likelihood of functional recovery
• 25-75% transmurality = Intermediate zone, consider adding low-dose dobutamine CMR
• >75% transmurality = Non-viable scar, unlikely to recover 1

Step 3: For Indeterminate Cases (25-75% transmurality)

Add low-dose dobutamine stress CMR to the same session or schedule separately. This combination achieves 95% sensitivity and 51% specificity for predicting recovery 1. Contractile reserve during dobutamine infusion (10 μg/kg/min) strongly predicts functional improvement post-revascularization 1.

When to Consider Alternative Modalities

Use FDG-PET Instead If:

• Gadolinium contraindicated (severe renal dysfunction, pregnancy, allergy)
• CMR not available or patient has contraindications (certain metallic implants, severe claustrophobia)
• Need to differentiate hibernating from scarred myocardium with highest sensitivity

FDG-PET demonstrates 92% sensitivity and 63% specificity for predicting regional functional recovery 1. The perfusion-metabolism mismatch pattern (reduced perfusion but preserved FDG uptake) is the hallmark of hibernating myocardium that will recover with revascularization 1.

SPECT Has Limited Role

While widely available, SPECT shows 87% sensitivity but only 54% specificity 1. It's reasonable only when CMR and PET are unavailable, but recognize its inferior performance for viability assessment.

Critical Pitfalls to Avoid

1. Don't rely on wall thickness alone: Segments <5.5 mm thick can still be viable if scar transmurality is <50% 1

2. Recognize LGE limitations in intermediate transmurality: The 25-75% zone has poor specificity (51%) and requires dobutamine augmentation 1

3. Timing matters: In acute MI (first 2-7 days), myocardial edema can confound interpretation. Native T1 mapping shows increased values in both viable edematous and non-viable tissue 1

4. Viability doesn't guarantee recovery: Presence of ≥10 viable segments predicts >3% LVEF improvement with 95% sensitivity and 75% specificity, but advanced LV remodeling and incomplete revascularization can prevent functional recovery 1

Prognostic Value

LGE extent is an independent predictor of mortality with incremental value beyond LVEF. LGE volume >23% carries a hazard ratio of 6.1 for adverse events 1. This prognostic information guides not just revascularization decisions but also ICD placement and heart failure management.

Cost-Effectiveness Consideration

Despite higher upfront costs than SPECT, CMR provides comprehensive anatomic and functional data in a single study without radiation exposure, making it cost-effective when considering the totality of information obtained 1.